Literature DB >> 6263637

The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone.

A E Takemori, D L Larson, P S Portoghese.   

Abstract

The fumaramate methyl ester derivatives of naltrexone (beta-FNA) and oxymorphone (beta-FOA) were both found to be reversible agonists on the guinea pig ileal longitudinal muscle preparation. In addition, beta-FNA possessed on irreversible antagonistic effect against morphine whereas beta-FOA had no such capacity. Analysis by pA2 values revealed that beta-FOA resembled pure agonists like morphine and enkephalin while beta-FNA resembled the mixed agonist-antagonists like nalorphine and pentazocine. The antagonism by beta-FNA was very selective in that it antagonized pure agonists but had little or no effect on the effects of either mixed agonist-antagonists, ethylketocyclazocine or other non-opiate-type agonists like norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263637     DOI: 10.1016/0014-2999(81)90355-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  31 in total

1.  delta opioid receptor modulation of several voltage-dependent Ca(2+) currents in rat sensory neurons.

Authors:  C G Acosta; H S López
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Tonic inhibitory control exerted by opioid peptides in the paraventricular nuclei of the hypothalamus on regional hemodynamic activity in rats.

Authors:  Andrée Lessard; Hélène Bachelard
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

3.  Interaction of opioids with antidepressant-induced antinociception.

Authors:  F Sierralta; G Pinardi; M Mendez; H F Miranda
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

4.  Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.

Authors:  Yunyun Yuan; Saheem A Zaidi; Orgil Elbegdorj; Lindsey C K Aschenbach; Guo Li; David L Stevens; Krista L Scoggins; William L Dewey; Dana E Selley; Yan Zhang
Journal:  J Med Chem       Date:  2013-11-07       Impact factor: 7.446

5.  Synthesis and Pharmacology of a Novel κ Opioid Receptor (KOR) Agonist with a 1,3,5-Trioxazatriquinane Skeleton.

Authors:  Shigeto Hirayama; Naohisa Wada; Toru Nemoto; Takashi Iwai; Hideaki Fujii; Hiroshi Nagase
Journal:  ACS Med Chem Lett       Date:  2014-06-26       Impact factor: 4.345

6.  Proceedings of the British Pharmacological Society. University of Dundee, 11th-14th September, 1984. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

7.  Affinity labeling mu opioid receptors with novel radioligands.

Authors:  Ke Yang; Amy Zuckerman; Gavril W Pasternak
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

8.  Multiple opiate receptors in the guinea pig enteric nervous system: unmasking the copresence of receptor subtypes.

Authors:  A R Gintzler; D Hyde
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Multiple opioid receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo.

Authors:  R D'Amato; J W Holaday
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.

Authors:  András Váradi; Gina F Marrone; Shainnel O Eans; Michelle L Ganno; Joan J Subrath; Valerie Le Rouzic; Amanda Hunkele; Gavril W Pasternak; Jay P McLaughlin; Susruta Majumdar
Journal:  ACS Chem Neurosci       Date:  2015-09-14       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.